Previous reports have observed a discordance rate of EGFR mutation status between paired BrM and corresponding primary lung tumor samples from 19% to as high as 67% (25, 26), with BrM typically displaying a higher frequency of EGFR mutations than primary NSCLC tumors (79). Here, EGFR is linked to non-small cell lung carcinoma.